Literature DB >> 17109076

CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls.

C Nordin1, I Sjödin.   

Abstract

The sulphated cholecystokinin (CCK) octapeptide (CCK-8S), the CCK tetrapeptide (CCK-4), neuropeptide Y (NPY) and gamma-aminobutyric acid (GABA) were determined in cerebrospinal fluid (CSF) obtained from 11 pathological male gamblers and 11 healthy male controls. Compared with healthy controls, pathological male gamblers displayed higher concentrations of CCK-8S, CCK-4 and GABA (but not NPY). A gradient with decreasing concentrations from the first to the third 6-ml CSF fraction was found for CCK-8S, CCK-4 and NPY, but only in pathological gamblers. Disrupted gradients were found for GABA and for NPY in healthy controls. Given that CCK is a modulator of dopamine in the reward process, the increase in CCK-8S and CCK-4 is not unexpected. The high level of GABA in pathological gamblers is in conformity with a compensatory inhibitory action on noradrenergic neurons. The CSF gradient of CCK-8S and CCK-4 in pathological male gamblers (but not healthy controls) might indicate a difference in diurnal variation. The results obtained are in line with an altered CCK and GABA function in pathological gambling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109076     DOI: 10.1007/s00702-006-0593-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

Review 1.  Pathological gambling. A comprehensive review.

Authors:  Namrata Raylu; Tian P S Oei
Journal:  Clin Psychol Rev       Date:  2002-09

2.  Altered CSF taurine function in pathological gambling.

Authors:  Conny Nordin; Ingemar Sjödin
Journal:  J Psychiatr Res       Date:  2005-12-07       Impact factor: 4.791

3.  Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects.

Authors:  T Gunnarsson; T Eklundh; M Eriksson; G A Qureshi; S Sjöberg; C Nordin
Journal:  Regul Pept       Date:  1997-01-15

4.  Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.

Authors:  T Eklundh; T Gunnarsson; C Nordin
Journal:  Neuropsychobiology       Date:  2001-01       Impact factor: 2.328

5.  Pathological gambling. A psychobiological study.

Authors:  A Roy; B Adinoff; L Roehrich; D Lamparski; R Custer; V Lorenz; M Barbaccia; A Guidotti; E Costa; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1988-04

6.  Quantitation of free amino acids in biological samples by high-performance liquid chromatography. Application of the method in evaluating amino acid levels in cerebrospinal fluid and plasma of patients with multiple sclerosis.

Authors:  G A Qureshi; M S Baig
Journal:  J Chromatogr       Date:  1988-12-28

7.  Intraspinal pressure influences CSF disposition of tryptophan and 5-HIAA.

Authors:  T Eklundh; C Nordin
Journal:  Neuropsychobiology       Date:  2001       Impact factor: 2.328

Review 8.  Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Authors:  K Blum; E R Braverman; J M Holder; J F Lubar; V J Monastra; D Miller; J O Lubar; T J Chen; D E Comings
Journal:  J Psychoactive Drugs       Date:  2000-11

Review 9.  Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

Authors:  Susan Rotzinger; Franco J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

10.  Temperament and character in pathological gambling.

Authors:  Conny Nordin; Per-Olof Nylander
Journal:  J Gambl Stud       Date:  2007-06
View more
  2 in total

1.  Evidence for GABA-A receptor dysregulation in gambling disorder: correlation with impulsivity.

Authors:  Inge Mick; Anna C Ramos; Jim Myers; Paul R Stokes; Samantha Chandrasekera; David Erritzoe; Maria A Mendez; Roger N Gunn; Eugenii A Rabiner; Graham E Searle; José C F Galduróz; Adam D Waldman; Henrietta Bowden-Jones; Luke Clark; David J Nutt; Anne R Lingford-Hughes
Journal:  Addict Biol       Date:  2016-10-13       Impact factor: 4.280

Review 2.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.